Intuitive Surgical
ISRGQ2 2024(ISRG Q1 FY2024)Estimated2.5% AI
AI Revenue %
2.5%
AI Fair Value
$1.9B
AI Revenue (Q)
$47.3M
Total Revenue (Q)
$1.9B
Source: SEC EDGAR 10-K Filing
View 10-K on SEC.govAnalysis
Q1 FY2024 total revenue $1,890.6M (Product $1,577.1M, Service $313.5M). Revenue disaggregation in Q1 FY2024 filings shows only Product vs Service split (the detailed Instruments/Systems/Services breakdown is not shown in the extracted segment note for this period, which instead focuses on ASU 2023-07 and financial instruments). ISRG launched the da Vinci 5 system in 2024, which includes enhanced AI features (Force Feedback, improved 3D visualization, and AI-powered case analytics). The 10-K for FY2024 adds a new Risk Factor: 'Incorporating artificial intelligence technologies into our products, services, and operations may result in legal and regulatory risks.' This is the first explicit AI risk factor, indicating growing AI integration. The company also describes a 'digital portfolio that enables actionable digital insights across the care continuum.' Slight uptick to 2.5% reflects the da Vinci 5 launch with enhanced AI features, but the vast majority of revenue still comes from the installed base of non-AI-enhanced systems and mechanical instruments/accessories.
Analyzed by claude-opus-4-6
Quoted Figures
Total revenue $1,890.6M (Product $1,577.1M, Service $313.5M)
10-Q 2024-03-31, Income Statement
Incorporating artificial intelligence technologies into our products, services, and operations may result in legal and regulatory risks or have other adverse consequences
10-K 2024-12-31, Risk Factors
AI Products Identified (Ring 1)
da Vinci 5 AI-enhanced visionMy Intuitive case analyticsdigital insights portfolioIon endoluminal vision probe
AI-Enabled Items (Ring 2 — Not Counted)
These items use AI but are not counted in the AI revenue estimate because they primarily serve non-AI functions.
Instruments & Accessoriesda Vinci Xi/X systems (non-AI)Systems hardware
Confidence Tier
EstimatedNo direct AI revenue disclosure — estimated from product mix